Scholarlink

Background <p>To evaluate macular microvascular changes measured by optical coherence tomography angiography (OCTA) in patients with inactive Graves’ ophthalmopathy (GO) compared with healthy controls by performing a meta-analysis of published studies.</p> Methods <p>A systematic literature search of PubMed, Scopus, and Web of Science was performed through August 2025 according to PRISMA guidelines. The inclusion criteria were original peer-reviewed studies comparing OCTA macular vessel density (VD) parameters or foveal avascular zone (FAZ) area between inactive GO patients (clinical activity score &lt; 3) and healthy controls, with means and standard deviations reported. Extracted outcomes included foveal VD, parafoveal VD, parafoveal temporal/superior/nasal/inferior VD, and FAZ area. Effect sizes were calculated as Hedges’ g with 95% confidence intervals (CIs). Heterogeneity was assessed with Cochran’s Q and I<sup>2</sup>; fixed or random effects models were applied accordingly. Publication bias was evaluated using Egger’s test.</p> Results <p>Six studies met inclusion criteria, comprising 433 eyes from inactive GO patients and 380 eyes from healthy controls. Meta-analysis found no significant differences between inactive GO patients and controls for: foveal VD (Hedges’ g = 0.040, 95% CI=[− 0.121 to 0.201], <i>p</i> = 0.628, I<sup>2</sup> = 0%), parafoveal VD (Hedges’ g = 0.044, 95% CI=[− 0.357 to 0.445], <i>p</i> = 0.830, I<sup>2</sup> = 73.5%), parafoveal temporal VD (Hedges’ g = 0.063, 95% CI=[− 0.212 to 0.337], <i>p</i> = 0.656, I<sup>2</sup> = 70%), parafoveal superior VD (Hedges’ g = 0.043, 95% CI=[− 0.293 to 0.380], <i>p</i> = 0.801, I<sup>2</sup> = 80%), parafoveal inferior VD (Hedges’ g = 0.176, 95% CI=[− 0.132 to 0.585], <i>p</i> = 0.263, I<sup>2</sup> = 76%), parafoveal nasal VD (Hedges’ g = − 0.043, 95% CI=[− 0.334 to 0.246], <i>p</i> = 0.775, I<sup>2</sup> = 73.3%), and FAZ area (Hedges’ g = 0.248, 95% CI=[− 0.207 to 0.703], <i>p</i> = 0.286, I<sup>2</sup> = 70.2%). Egger’s tests did not indicate significant publication bias for the analyzed outcomes. Moderate to high heterogeneity was observed for most parameters except foveal VD.</p> Conclusion <p>This meta-analysis revealed no significant differences in macular VD and FAZ area between inactive GO patients and healthy controls. The absence of differences suggests that macular microvascular alterations in GO may be associated primarily with active inflammatory disease and may normalize in inactive stages, or that macular VD is not a sensitive biomarker for inactive disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of parafoveal region and foveal avascular zone in inactive Graves’ ophthalmopathy using optical coherence tomography angiography: a meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月26日

查看全文
  • Sibel Balcı,
  • Büşra Yılmaz Tuğan

摘要

Background

To evaluate macular microvascular changes measured by optical coherence tomography angiography (OCTA) in patients with inactive Graves’ ophthalmopathy (GO) compared with healthy controls by performing a meta-analysis of published studies.

Methods

A systematic literature search of PubMed, Scopus, and Web of Science was performed through August 2025 according to PRISMA guidelines. The inclusion criteria were original peer-reviewed studies comparing OCTA macular vessel density (VD) parameters or foveal avascular zone (FAZ) area between inactive GO patients (clinical activity score < 3) and healthy controls, with means and standard deviations reported. Extracted outcomes included foveal VD, parafoveal VD, parafoveal temporal/superior/nasal/inferior VD, and FAZ area. Effect sizes were calculated as Hedges’ g with 95% confidence intervals (CIs). Heterogeneity was assessed with Cochran’s Q and I2; fixed or random effects models were applied accordingly. Publication bias was evaluated using Egger’s test.

Results

Six studies met inclusion criteria, comprising 433 eyes from inactive GO patients and 380 eyes from healthy controls. Meta-analysis found no significant differences between inactive GO patients and controls for: foveal VD (Hedges’ g = 0.040, 95% CI=[− 0.121 to 0.201], p = 0.628, I2 = 0%), parafoveal VD (Hedges’ g = 0.044, 95% CI=[− 0.357 to 0.445], p = 0.830, I2 = 73.5%), parafoveal temporal VD (Hedges’ g = 0.063, 95% CI=[− 0.212 to 0.337], p = 0.656, I2 = 70%), parafoveal superior VD (Hedges’ g = 0.043, 95% CI=[− 0.293 to 0.380], p = 0.801, I2 = 80%), parafoveal inferior VD (Hedges’ g = 0.176, 95% CI=[− 0.132 to 0.585], p = 0.263, I2 = 76%), parafoveal nasal VD (Hedges’ g = − 0.043, 95% CI=[− 0.334 to 0.246], p = 0.775, I2 = 73.3%), and FAZ area (Hedges’ g = 0.248, 95% CI=[− 0.207 to 0.703], p = 0.286, I2 = 70.2%). Egger’s tests did not indicate significant publication bias for the analyzed outcomes. Moderate to high heterogeneity was observed for most parameters except foveal VD.

Conclusion

This meta-analysis revealed no significant differences in macular VD and FAZ area between inactive GO patients and healthy controls. The absence of differences suggests that macular microvascular alterations in GO may be associated primarily with active inflammatory disease and may normalize in inactive stages, or that macular VD is not a sensitive biomarker for inactive disease.